Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemia by Roberta Buono, Muneera Alhaddad, Muneera Alhaddad, David A. Fruman

Get full text

Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1. by Sharmila Mallya, Briana A Fitch, J Scott Lee, Lomon So, Matthew R Janes, David A Fruman

Get full text

Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition by Thanh-Trang Vo, Lee-or Herzog, Roberta Buono, Jong-Hoon Scott Lee, Sharmila Mallya, Madeleine R. Duong, Joshua Thao, Moran Gotesman, David A. Fruman

Get full text

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer by Antonino Glaviano, Aaron S. C. Foo, Hiu Y. Lam, Kenneth C. H. Yap, William Jacot, Robert H. Jones, Huiyan Eng, Madhumathy G. Nair, Pooyan Makvandi, Birgit Geoerger, Matthew H. Kulke, Richard D. Baird, Jyothi S. Prabhu, Daniela Carbone, Camilla Pecoraro, Daniel B. L. Teh, Gautam Sethi, Vincenzo Cavalieri, Kevin H. Lin, Nathalie R. Javidi-Sharifi, Eneda Toska, Matthew S. Davids, Jennifer R. Brown, Patrizia Diana, Justin Stebbing, David A. Fruman, Alan P. Kumar

Get full text